- Home
- NGEN vs NRC Comparison
NGEN vs NRC Comparison
Compare NGEN & NRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NGEN | NRC |
|---|---|---|
| Founded | 2017 | 1981 |
| Country | Canada | United States |
| Employees | 14 | N/A |
| Industry | | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 337.4M | 390.8M |
| IPO Year | N/A | 1997 |
Fundamental Metrics
Financial Performance| Metric | NGEN | NRC |
|---|---|---|
| Price | $4.12 | $16.91 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 196.4K | 72.5K |
| Earning Date | 04-02-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 3.81% |
| EPS Growth | N/A | ★ 4707.69 |
| EPS | N/A | ★ 50.00 |
| Revenue | N/A | ★ $119,686,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $0.34 |
| Revenue Growth | N/A | ★ 1.81 |
| 52 Week Low | $3.51 | $9.76 |
| 52 Week High | $5.93 | $22.79 |
Technical Indicators
Market Signals| Indicator | NGEN | NRC |
|---|---|---|
| Relative Strength Index (RSI) | 51.69 | 53.52 |
| Support Level | $3.65 | $16.64 |
| Resistance Level | $4.52 | $18.29 |
| Average True Range (ATR) | 0.28 | 0.74 |
| MACD | 0.03 | -0.11 |
| Stochastic Oscillator | 54.31 | 45.79 |
Price Performance
Historical ComparisonAbout NGEN NervGen Pharma Corp. Common stock
NervGen Pharma Corp is a clinical-stage biotech company. The company's principal business activity is the discovery, development, and commercialization of pharmaceutical treatments that enable the nervous system to repair itself following damage, whether due to injury or disease. The company's initial target indication is spinal cord injury. The company's pipeline products include NVG-291 and NVG-300.
About NRC National Research Corporation (Delaware)
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. The company operates in the United States and Canada, of which key revenue is derived from the United States.